Terms: = Kidney tumors AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Treatment
104 results:
1. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
2. Improved therapy for clear cell renal cell carcinoma: beta-hydroxybutyrate and quercetin target hypoxia-induced angiogenesis and multidrug resistance.
Mohammadipoor N; Naiebi R; Mazhari SA; Amooei F; Owrang M; Dastghaib S; Shams M; Maleki MH; Dastghaib S
Mol Biol Rep; 2024 Mar; 51(1):379. PubMed ID: 38429605
[TBL] [Abstract] [Full Text] [Related]
3. Long non-coding RNA hif1a-AS2 promotes carcinogenesis by enhancing Gli1-mediated HIF1α expression in clear cell renal cell carcinoma.
Li X; Wu Y; Xiao Z; Liu Y; Wang C; Zhou L; Yang X
Pathol Res Pract; 2024 Jan; 253():154984. PubMed ID: 38064865
[TBL] [Abstract] [Full Text] [Related]
4. [Activation of HIF-1α/ACLY signaling axis promotes progression of clear cell renal cell carcinoma with VHL inactivation mutation].
Ma Y; Wang YH; Huang S; Zou ZG; Hu L; Guo LC
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1230-1236. PubMed ID: 38058039
[No Abstract] [Full Text] [Related]
5. Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation.
Liu T; Xiang W; Chen Z; Wang G; Cao R; Zhou F; Meng Z; Luo Y; Chen L
Cell Death Dis; 2023 Nov; 14(11):774. PubMed ID: 38008826
[TBL] [Abstract] [Full Text] [Related]
6. Evolution of the HIF targeted therapy in clear cell renal cell carcinoma.
Golijanin B; Malshy K; Khaleel S; Lagos G; Amin A; Cheng L; Golijanin D; Mega A
Cancer Treat Rev; 2023 Dec; 121():102645. PubMed ID: 37879247
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus.
Nakayama Y; Enomoto D; Yamamoto K; Takara K
Anticancer Res; 2023 Oct; 43(10):4349-4357. PubMed ID: 37772579
[TBL] [Abstract] [Full Text] [Related]
8. Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect.
Xue KH; Jiang YF; Bai JY; Zhang DZ; Chen YH; Ma JB; Zhu ZJ; Wang X; Guo P
Redox Rep; 2023 Dec; 28(1):2251234. PubMed ID: 37642220
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy, mechanism, and safety of melatonin-loaded on thermosensitive nanogels for rabbit VX2 tumor embolization: A novel design.
Chen L; Sun T; Lv Y; Lu X; Li X; Zhang H; Qian K; Guo X; Sun B; Zhang W; Zhu L; Huang J; Liu Y; Zhao H; Zhao Y; Liang B; Zheng C
J Pineal Res; 2023 Oct; 75(3):e12900. PubMed ID: 37492880
[TBL] [Abstract] [Full Text] [Related]
10. Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated tumors.
Suárez C; Vieito M; Valdivia A; González M; Carles J
Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
[TBL] [Abstract] [Full Text] [Related]
11. Propofol Regulates HIF-1 α Effect of Expression of Targeted SIRT1 Signal pathway on kidney Renal Clear Cell Carcinoma.
Chen X; Li C; Zeng R; Qiu L; Huang J; Wang N; Ren X; Ling X
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):145-149. PubMed ID: 37300675
[TBL] [Abstract] [Full Text] [Related]
12. Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma.
Sonawane V; Ghosalkar J; Achrekar S; Joshi K
Sci Rep; 2023 Apr; 13(1):5659. PubMed ID: 37024613
[TBL] [Abstract] [Full Text] [Related]
13. Docetaxel suppressed cell proliferation through Smad3/HIF-1α-mediated glycolysis in prostate cancer cells.
Peng J; He Z; Yuan Y; Xie J; Zhou Y; Guo B; Guo J
Cell Commun Signal; 2022 Dec; 20(1):194. PubMed ID: 36536346
[TBL] [Abstract] [Full Text] [Related]
14. Isoform-resolved mRNA profiling of ribosome load defines interplay of HIF and mTOR dysregulation in kidney cancer.
Sugimoto Y; Ratcliffe PJ
Nat Struct Mol Biol; 2022 Sep; 29(9):871-880. PubMed ID: 36097292
[TBL] [Abstract] [Full Text] [Related]
15. Future treatment options in metastatic clear cell renal cell carcinoma.
Simonaggio A; Auvray-Kuentz M; Rochand A; Thibault C; Gervais C; Oudard S; Vano YA
Bull Cancer; 2022 May; 109(2S):2S47-2S58. PubMed ID: 35760471
[TBL] [Abstract] [Full Text] [Related]
16. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract] [Full Text] [Related]
17. Wild-type IDH1 inhibits the tumor growth through degrading HIF-α in renal cell carcinoma.
Chen S; Wang Y; Xiong Y; Peng T; Lu M; Zhang L; Guo Z
Int J Biol Sci; 2021; 17(5):1250-1262. PubMed ID: 33867843
[TBL] [Abstract] [Full Text] [Related]
18. Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab treatment in Patients with Advanced Renal Cell Carcinoma.
Martini JF; Plimack ER; Choueiri TK; McDermott DF; Puzanov I; Fishman MN; Cho DC; Vaishampayan U; Rosbrook B; Fernandez KC; Tarazi JC; George S; Atkins MB
Clin Cancer Res; 2020 Nov; 26(21):5598-5608. PubMed ID: 32816890
[TBL] [Abstract] [Full Text] [Related]
19. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
Aslan C; Maralbashi S; Kahroba H; Asadi M; Soltani-Zangbar MS; Javadian M; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
Life Sci; 2020 Oct; 258():118094. PubMed ID: 32673663
[TBL] [Abstract] [Full Text] [Related]
20. Anterior gradient 2 promotes tumorigenesis through upregulation of CCAAT-enhancer binding protein beta and hypoxia-inducible factor-2α and subsequent secretion of interleukin-6, interleukin-8, and vascular endothelial growth factor in the Caki-1 clear cell renal cell carcinoma cell line.
Pajdzik K; Wilamowski M; Żurawek D; Stopa KB; Nodzyński M; Kalita A; Jura J
IUBMB Life; 2020 Aug; 72(8):1807-1818. PubMed ID: 32593213
[TBL] [Abstract] [Full Text] [Related]
[Next]
